Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Natl Cancer Inst

Retrieve available abstracts of 11 articles:
HTML format

Single Articles

    February 2022
  1. TANAKA I, Dayde D, Tai MC, Mori H, et al
    SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.
    J Natl Cancer Inst. 2022;114:290-301.
    PubMed     Abstract available

  2. HEIN DM, Deng W, Bleile M, Kazmi SA, et al
    Racial and Ethnic Differences in Genomic Profiling of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2022 Feb 2. pii: 6520467. doi: 10.1093.
    PubMed     Abstract available

    October 2021
  3. BAKSHI A, Yan M, Riaz M, Polekhina G, et al
    Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.
    J Natl Cancer Inst. 2021;113:1379-1385.
    PubMed     Abstract available

    September 2021
  4. VARGHESE AM, Singh I, Singh R, Kunte S, et al
    Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes.
    J Natl Cancer Inst. 2021;113:1194-1202.
    PubMed     Abstract available

    July 2021
  5. SEMBA T, Wang X, Xie X, Cohen EN, et al
    Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment.
    J Natl Cancer Inst. 2021 Jul 12. pii: 6313157. doi: 10.1093.
    PubMed     Abstract available

    March 2021
    Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy.
    J Natl Cancer Inst. 2021;113:223-224.

    May 2020
  7. YABROFF KR, Zhao J, de Moor JS, Sineshaw HM, et al
    Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.
    J Natl Cancer Inst. 2020;112:498-506.
    PubMed     Abstract available

    April 2020
  8. KATONA BW, Clark DF, Domchek SM
    CDH1 on Multigene Panel Testing: Look Before You Leap.
    J Natl Cancer Inst. 2020;112:330-334.
    PubMed     Abstract available

    May 2019
  9. VOS JR, Fakkert IE, de Hullu JA, van Altena AM, et al
    Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.
    J Natl Cancer Inst. 2019 May 11. pii: 5488012. doi: 10.1093.
    PubMed     Abstract available

    April 2019
  10. XU Z, Sandler DP, Taylor JA
    Blood DNA methylation and breast cancer: A prospective case-cohort analysis in the Sister Study.
    J Natl Cancer Inst. 2019 Apr 15. pii: 5466458. doi: 10.1093.
    PubMed     Abstract available

    February 2019
  11. NGUYEN B, Veys I, Leduc S, Bareche Y, et al
    Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer.
    J Natl Cancer Inst. 2019 Feb 21. pii: 5355042. doi: 10.1093.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.